electroCore (ECOR) Non-Current Debt (2020 - 2026)

electroCore (ECOR) recorded quarterly Non-Current Debt of $6.4 million in Q1 2026, down 2.57% quarter-over-quarter from $6.6 million in Q4 2025.

electroCore (ECOR) Non-Current Debt (2020 - 2026) Analysis & Trends

electroCore's Non-Current Debt history runs 4 years deep, the most recent figure standing at $6.4 million for Q1 2026.

In Q1 2026, Non-Current Debt changed N/A year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $6.4 million (changed N/A YoY), while the FY2025 annual figure was $6.6 million, changed N/A from the prior year.
Non-Current Debt was $6.4 million for Q1 2026 at electroCore, down from $6.6 million in the prior quarter.
In the past five years, Non-Current Debt ranged from a high of $6.6 million in Q4 2025 to a low of $6.4 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	29.64 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	14.22 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	27.88 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	10.99 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	598.50 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	8.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	10.13 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	1.81 Bn
10	electroCore	75,742.38	-8.80 Mn	8.36 Mn	6.44 Mn

Download Data